Long-term prognosis of @entity1 with XXXX .

@entity1 @entity5968 @entity301 @entity1855 @entity3988 @entity1188 @entity951 @entity594 @entity583 @entity204
The long-term prognosis of @entity5968 and the factors influencing it were assessed in 217 consecutive @entity1 hospitalized in our coronary care unit and followed for a mean of 65 months (range 2 to 123). @entity204 occurred in 30 @entity1 and an additional 54 experienced a nonfatal @entity583 . Survival at 1 and 5 years was 95% and 89%, respectively; survival without @entity1188 was 83% and 69%. @entity301 activity were strong predictors of survival by Cox analysis. Survival at 1 year was 99%, and that at 5 years was 95% and 94%, respectively, for @entity1 with one-vessel disease (n = 81) and for those without stenoses of 70% or greater (n = 87). Survival at 1 and 5 years was only 87% and 77% for those with multivessel disease (n = 40). The Cox analysis selected left ventricular function, initial treatment, extent score, duration of @entity951 at rest, and disease activity as multivariate predictors of survival without @entity1188 . @entity301 was a strong predictor (p less than .0001) of survival without @entity1188 by univariate analysis. Treatment with @entity594 , @entity3988 , or @entity1855 improved survival without @entity1188 compared with other medical treatment (p = .002). @entity583 occurred most commonly soon after diagnosis in @entity1 with a short history of @entity951 at rest. Late coronary events were almost never preceded by resting @entity951 .
